Masimo Receives European Union Medical Device Regulation CE Mark For LiDCO® Module For Hemodynamic Monitoring
Portfolio Pulse from Benzinga Newsdesk
Masimo Corporation has received the European Union Medical Device Regulation CE Mark for its LiDCO module for hemodynamic monitoring. This approval allows the company to market and sell the product in the European Union.
October 09, 2023 | 6:14 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Masimo Corporation's receipt of the EU Medical Device Regulation CE Mark for its LiDCO module for hemodynamic monitoring could potentially boost its sales and market presence in the European Union.
The approval of Masimo's LiDCO module by the EU Medical Device Regulation CE Mark allows the company to market and sell the product in the European Union. This could potentially increase the company's sales and expand its market presence in the region, which could have a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100